Please assess the completion status of the following clinical trial:

Trial Title: Compare Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Treatment of adults with moderate to severe plaque psoriasis who failed to respond to, or who have a contraindication to, or are intolerant to other systemic therapy including cyclosporine, methotrexate or PUVA~* Eligible for treatment with etanercept according to Summary of Product Characteristics (SmPC), and applicable local guidelines.~* Aged 18 years or more~* Willing and able to self-inject etanercept.~* Able to store test drug at 2-8oC.~* Negative serum ß-human chorionic gonadotropin (ß-HCG) pregnancy test at baseline (week 0) for all women of childbearing potential. Sexually active women of childbearing potential must use a medically acceptable form of contraception. Medically acceptable forms of contraception include oral contraceptives, injectable or implantable methods, intrauterine devices, or properly used barrier contraception. Sexually active men must agree to use a reliable form of contraception during the study.~* Capable of understanding and willing to provide signed and dated written voluntary informed consent before any protocol-specific procedures are performed.~Exclusion Criteria:~* Prior experience of biologics and anti-TNF treatment for their Psoriasis including etanercept.~* Sepsis or risk of sepsis.~* Current or recent infections, including chronic or localized.~* Latex sensitivity.~* Vaccination with live vaccine in last 4 weeks, or expected to require such vaccination during the course of the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Arm 1: Enbrel 50 mg Prefilled Syringe
- 2 (Type: ACTIVE_COMPARATOR): Arm 2 Enbrel 50 mg Autoinjector

Based on this trial design, predict the completion outcome and termination type (if applicable).